1.
Results of Weibull regression models for the interval between last exposure and testing in days–first RDT study.
2.
3.
Results of Weibull regression models for the interval between last exposure and testing in days–second RDT study.
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study.
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice.
Missing data.
Study timeline.
Prevalence and diagnostic delay.
Stratification of diagnostic delay patients per group.
Odds ratio (OR) and the 95% confidence interval (95% CI) for different variables without smoking (complete analyses).
Odds ratio (OR) and the 95% confidence interval (95% CI) for different variables with smoking (multiple imputation).